Pacific Biosciences - Top 20 VC deals of 2008

Pacific Biosciences, FierceBiotech top venture capital deal awardCompany: Pacific Biosciences
Based: Menlo Park, CA
Amount: $120M

Investors: Alloy Ventures, Kleiner Perkins Caufield & Byers, Maverick Capital,T. Rowe Price Threshold Partnerships, Intel Capital,Blackstone Group,Duff Ackerman & Goodrich, Undisclosed Firm, Morgan Stanley Private Equity, AllianceBernstein, Mohr Davidow Ventures

Scoop: Pacific Biosciences closed two deals in 2008 for a total of $120 million in funding. The company is developing the technology needed to complete a high-quality sequence of the human genome in 15 minutes. The money will be used to support its SMRT DNA sequencing platform.

Pacific Biosciences - Top 20 VC deals of 2008
Read more on

Suggested Articles

The drug failed a futility analysis in March, but Biogen resurrected it after factoring in data generated after the cutoff for the interim assessment.

The negative top-line data deal a big blow to the prospects of a drug analysts tipped to achieve blockbuster sales if it cleared phase 3.

Intrepida Bio launched with $9.5 million from Sofinnova and Canaan Partners to develop anti-BAG3 antibodies for the treatment of cancer.